Moderna’s long-running patent dispute with Pfizer and BioNTech intensified Tuesday after London’s High Court of Justice upheld one of Moderna’s key mRNA patents, but invalidated …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.